Listen for Gliptin Patients Complaining of Severe Joint Pain
A new FDA warning will spur questions about whether gliptins (Januvia, Onglyza, etc) cause severe joint pain.
This risk seems to be a class effect of gliptins, and it's very rare...but the pain can be disabling.
We know these diabetes meds inhibit dipeptidyl peptidase-4 (DPP-4)...an enzyme that breaks down incretin hormones.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: MD includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote